[go: up one dir, main page]

ATE285797T1 - In vivo assay zur prüfung der phänotypischen stabilität - Google Patents

In vivo assay zur prüfung der phänotypischen stabilität

Info

Publication number
ATE285797T1
ATE285797T1 AT00967443T AT00967443T ATE285797T1 AT E285797 T1 ATE285797 T1 AT E285797T1 AT 00967443 T AT00967443 T AT 00967443T AT 00967443 T AT00967443 T AT 00967443T AT E285797 T1 ATE285797 T1 AT E285797T1
Authority
AT
Austria
Prior art keywords
chondrocytes
stability
vivo assay
outcome
test
Prior art date
Application number
AT00967443T
Other languages
English (en)
Inventor
Frank Luyten
Bari Cosimo De
Accio Francesco Dell
Original Assignee
Tigenix Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tigenix Nv filed Critical Tigenix Nv
Application granted granted Critical
Publication of ATE285797T1 publication Critical patent/ATE285797T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT00967443T 1999-10-06 2000-10-06 In vivo assay zur prüfung der phänotypischen stabilität ATE285797T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99203273 1999-10-06
PCT/BE2000/000118 WO2001024833A2 (en) 1999-10-06 2000-10-06 In vivo assay for testing the phenotypic stability

Publications (1)

Publication Number Publication Date
ATE285797T1 true ATE285797T1 (de) 2005-01-15

Family

ID=8240723

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00967443T ATE285797T1 (de) 1999-10-06 2000-10-06 In vivo assay zur prüfung der phänotypischen stabilität

Country Status (12)

Country Link
US (2) US7479367B1 (de)
EP (2) EP1498146A3 (de)
AT (1) ATE285797T1 (de)
AU (1) AU7764200A (de)
CA (1) CA2397610C (de)
CY (1) CY2010007I1 (de)
DE (3) DE20023659U1 (de)
DK (1) DK1218037T3 (de)
ES (2) ES2488240T1 (de)
LU (1) LU91672I2 (de)
PT (1) PT1218037E (de)
WO (1) WO2001024833A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1218037E (pt) * 1999-10-06 2005-05-31 Tigenix Nv Ensaios in vitro e marcadores moleculares para testar a estabilidade fenotipica de populacoes de celulas, e populacoes de celulas seleccionadas para transplantacao autologa
US7482114B2 (en) 1999-10-06 2009-01-27 Tigenix N.V. In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation
AU2001266915A1 (en) 2000-06-14 2001-12-24 Case Western Reserve University Probes for chondrogenesis
WO2004013606A2 (en) * 2002-08-02 2004-02-12 Stratatech Corporation Species specific dna detection
NZ589814A (en) 2006-03-20 2012-03-30 Tigenix Nv Methods to maintain, improve and restore the cartilage phenotype of chondrocytes
US20100068715A1 (en) * 2006-11-24 2010-03-18 Tigenix N.V. Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production
CN101215565B (zh) * 2008-01-11 2011-04-27 华中农业大学 一种作为猪标记辅助选择的与免疫性状相关的分子标记的克隆及应用
GB0902793D0 (en) 2009-02-20 2009-04-08 Univ Gent GDF15 as molecular tool to monitor and enhance phenotypic stability of articular chondrocytes
EP3872168A1 (de) * 2020-02-28 2021-09-01 Cline Scientific AB Chondrozytendifferenzierung
KR20230052963A (ko) 2020-08-21 2023-04-20 젠자임 코포레이션 Fgfr3 항체 및 사용 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837258A (en) * 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
US5723331A (en) 1994-05-05 1998-03-03 Genzyme Corporation Methods and compositions for the repair of articular cartilage defects in mammals
US5902785A (en) * 1995-06-06 1999-05-11 Genetics Institute, Inc. Cartilage induction by bone morphogenetic proteins
JPH11507828A (ja) 1995-06-12 1999-07-13 イエーダ リサーチ アンド ディベロップメント カンパニー，リミテッド Ｆｇｆｒ３に対して特異的なリガンドとしてのｆｇｆ９
AU742342B2 (en) 1997-05-21 2001-12-20 Clontech Laboratories, Inc. Nucleic acid arrays
WO1998059035A2 (en) 1997-06-25 1998-12-30 The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health Serum-free cell growth medium
DK1282690T3 (da) * 1999-10-06 2005-02-28 Tigenix Nv Isolation af precursorceller og anvendelse deraf til vævsreparation
PT1218037E (pt) * 1999-10-06 2005-05-31 Tigenix Nv Ensaios in vitro e marcadores moleculares para testar a estabilidade fenotipica de populacoes de celulas, e populacoes de celulas seleccionadas para transplantacao autologa
US7482114B2 (en) 1999-10-06 2009-01-27 Tigenix N.V. In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation

Also Published As

Publication number Publication date
EP1498146A2 (de) 2005-01-19
EP1218037B1 (de) 2004-12-29
EP1218037A2 (de) 2002-07-03
CA2397610A1 (en) 2001-04-12
CY2010007I2 (el) 2010-07-28
AU7764200A (en) 2001-05-10
CY2010007I1 (el) 2010-07-28
DK1218037T3 (da) 2005-04-25
DE20023659U1 (de) 2005-07-07
PT1218037E (pt) 2005-05-31
US7479367B1 (en) 2009-01-20
DE122010000021I1 (de) 2012-09-06
CA2397610C (en) 2012-07-03
ES2234673T3 (es) 2005-07-01
US9089598B2 (en) 2015-07-28
LU91672I2 (fr) 2010-06-02
WO2001024833A2 (en) 2001-04-12
DE60017159T2 (de) 2006-05-04
EP1498146A3 (de) 2007-01-24
DE60017159D1 (de) 2005-02-03
ES2488240T1 (es) 2014-08-26
US20090162328A1 (en) 2009-06-25
WO2001024833A3 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
LU91672I2 (fr) ChondroCelect
Yamasaki et al. Meniscal regeneration using tissue engineering with a scaffold derived from a rat meniscus and mesenchymal stromal cells derived from rat bone marrow
SE9303977D0 (sv) Verfahren zur herstellung von implantatkeramikmaterial, insbesonders von hydroxylapatit aufweisenden implantatkeramikmaterial
ATE213590T1 (de) Fgf9 als spezifischer ligand für fgfr3
YU12201A (sh) Metodi, instrumenti i materijali za transplantaciju ćelija hondrocita
ZA985507B (en) Method for assessing disposable absorbent articles with improved skin dryness performance and with improved skin aeration
DE69828050D1 (de) Verfahren zur herstellung eines poly(vinyl)alkoholkryogels
DE60028666D1 (de) Verwendung von Fettgewebe-abgeleiteten Stromalen Zellen zur Differenzierung in Chondrozyten und ihre Verwendung zur Reparatur von Knorpelgewebe
DE69914849D1 (de) Polymerzusammensetzungen und Verfahren zur Schmutzlösen-Förderung von Geweben unter Verwendung dieser Polymerzusammensetzungen
BR9610357B1 (pt) composição sinterizada artificial bioativa, estrutura microporosa cerámica aparente, dispositivo implantável, processo para o cultivo de células de ossos funcionais e kit para monitorar e quantificar a atividade das referidas células
ATE387491T1 (de) Differenzierung vom gesamten knochenmark
DK0892849T3 (da) Fremgangsmåde til anvendelse af obese-genet og dets genprodukt til stimulering af hæmatopoietisk udvikling
DE69934179D1 (de) Zusammensetzung enthaltend, ein Antigen, ein TH-1 induzierendes Adjuvans und eine im Wasser schwer lösliche Aminosäure, zur Verwendung in der Immunisierung
ATE429450T1 (de) Chimärische dr4 antikörper und ihre verwendung
DK0783693T3 (da) In vitro-modeller for CNS-funktion og -dysfunktion
ID30073A (id) Metode untuk menyambung, menandai dan memodifikasi secara struktural monofilamen-monofilamen
DE69906745D1 (de) Quellbares saugfähiges produkt und verfahren zu seiner herstellung
DK0726796T3 (da) Syntetisk græsimplantat til markering på jorden af græsklædte flader
DE60034672D1 (de) Reporterverbindungen und verfahren zur bestimmung des lipidisierungsstatus einer zelle
ATE481641T1 (de) Verfahren zur fixierung eines proteins auf einem pyrrolpolymerisat, und dessen verwendung zur herstellung eines sensors
DE59507162D1 (de) Verfahren zur Befestigung von Hängen
ES2151895T3 (es) Procedimiento para la obtencion de cultivos celulares con alto contenido en citoquinas endogenas.
EP1094158A3 (de) Verfahren und Vorrichtung zum Befestigen von Leitpflöcken, Leitschienen und dergleichen
DE60026272D1 (de) Verwendung eines Papillarfibroblast-spezifischen Antikörpers als Marker der Hautqualität
ATE103390T1 (de) Verfahren zur bestimmung der endothelialzellenbedeckung einer kuenstlichen oberflaeche.